Basic science advances in head and neck oncology: the past decade

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Head and neck cancer natural history is evolving with new research.
• Environmental carcinogen exposure can be quantified via DNA adducts.
• Subclinical genetic abnormalities exist in histopathologically normal mucosa of cancer patients.

Purpose of the Study:

• To re-evaluate the natural history of head and neck cancer.
• To identify early molecular markers and understand disease progression.
• To explore novel therapeutic strategies based on recent advances.

Main Methods:

• Quantification and characterization of environmental carcinogens bound to mucosal DNA.
• Analysis of genetic abnormalities in head and neck cancer patients' mucosa, including DNA content and gene mutations.
• Investigation of growth factors and receptors in tumor progression.
• Characterization of disease invasion and metastasis processes.
• Assessment of genetic instability in advanced head and neck cancer.

Main Results:

• DNA adducts serve as quantitative markers for early disease processes.
• Head and neck cancer patients exhibit genetic abnormalities in normal-appearing mucosa.
• Aberrant cellular proliferation and differentiation are linked to subclinical events.
• Disease progression is characterized by increasing genetic instability and mutational events.
• A biological basis for treatment resistance is being elucidated.

Conclusions:

• Head and neck cancer progression is a dynamic, genetically driven process.
• Early molecular changes and genetic instability provide therapeutic targets.
• Novel treatment strategies including monoclonal antibodies, cytokines, and gene therapy are emerging.